Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021
Addictive Behaviors · 2023-05 · 140 · 107617
DOI: 10.1016/j.addbeh.2023.107617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addictive Behaviors, 2023-05. Verfasst von Deborah S Hasin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032, USA; New York State Psychiatric Instit…. Hauptthemen laut MEDLINE: Cannabis, Hallucinogens, Medical Marijuana. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Compared to plant/flower cannabis products, cannabis concentrates have higher average potency of delta-9-tetrahydrocannabinol (Δ9-THC), which may be associated with greater likelihood of cannabis-related harms. Information on factors associated with use of cannabis concentrates is needed. METHODS: Respondents were 4,328 adult past-7-day cannabis users from all 50 U.S. states and Washington DC (DC) who participated in an online 2021 survey. Using logistic regression to generate adjusted odds ratios (aOR), we investigated whether participants in states that enacted recreational cannabis laws (RCL, 12 states plus DC [treated as a state], n = 1,236) or medical cannabis laws (MCL-only, 23 states, n = 2,030) by December 31, 2020 were more likely than those in states without cannabis laws (no-CL, 15 states, n = 1,062) to use cannabis concentrate products in the prior 7 days. RESULTS: Most participants (92.4%) used plant material in the prior 7 days; 57.0% used cannabis concentrates. In RCL, MCL and no-CL states, concentrate use was reported by 61.5%, 56.6%, and 52.5%, respectively. Compared to participants in no-CL states, odds of using cannabis concentrate products were greater among those in RCL states (aOR = 1.47; CI = 1.17-1.84) and MCL-only states (aOR = 1.29; CI = 1.08-1.55). Whether states had legally-authorized dispensaries had little effect on results. CONCLUSION: Results suggest that individuals in MCL-only and RCL states are more likely to use cannabis concentrate products. Determining mechanisms underlying these results, e.g., commercialization, could provide important information for prevention. Clinicians should be alert to patient use of concentrates, especially in MCL-only and RCL states. Continued monitoring is warranted as additional states legalize cannabis use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032, USA; New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA; Department of Epid…
- Department of Psychiatry, Dartmouth Geisel School of Medicine, One Medical Center Drive, Lebanon, NH 03756, USA. Electronic address: jacob.t.borodovsky@dartmouth.edu.
- Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032, USA; New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA. Electronic address…
- New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA. Electronic address: claire.walsh@nyspi.columbia.edu.
- Department of Psychiatry, Dartmouth Geisel School of Medicine, One Medical Center Drive, Lebanon, NH 03756, USA. Electronic address: cara.a.struble@dartmouth.edu.
- Department of Psychiatry, Dartmouth Geisel School of Medicine, One Medical Center Drive, Lebanon, NH 03756, USA. Electronic address: mohammad.i.habib@dartmouth.edu.
Förderung
- NIDA NIH HHS
Zitieren
APA
Hasin, D. S., Borodovsky, J., Shmulewitz, D., Walsh, C., Struble, C. A., Livne, O., Habib, M. I., Fink, D. S., Aharonovich, E., & Budney, A. (2023). Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021. Addictive Behaviors, 140, 107617. https://doi.org/10.1016/j.addbeh.2023.107617
Vancouver
Hasin DS, Borodovsky J, Shmulewitz D, Walsh C, Struble CA, Livne O, et al. Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021. Addictive Behaviors. 2023;140:107617. doi:10.1016/j.addbeh.2023.107617
BibTeX
@article{Hasin2023,
author = {Hasin, Deborah S and Borodovsky, Jacob and Shmulewitz, Dvora and Walsh, Claire and Struble, Cara A and Livne, Ofir and Habib, Mohammad I and Fink, David S and Aharonovich, Efrat and Budney, Alan},
title = {Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021},
journal = {Addictive Behaviors},
year = {2023},
volume = {140},
pages = {107617},
doi = {10.1016/j.addbeh.2023.107617}
}
EUVIMED